Rockwell Medical (RMTI) Non-Current Debt (2013 - 2026)

Rockwell Medical has reported Non-Current Debt for 11 years, with the latest figure at $8.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 4.11% year-over-year to $8.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (down 4.11% YoY), and the FY2025 full-year result was $8.8 million, up 4.18% from the prior year.
• Non-Current Debt for Q1 2026 stood at $8.2 million, down from $8.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $11.8 million in Q1 2022, with the low at $3.3 million in Q3 2023.
• Historically, Non-Current Debt has averaged $8.1 million across 5 years, with a median of $8.4 million in 2024.
• Annual changes were most pronounced in 2023 — Non-Current Debt plunged 62.83% — and 2024, when it soared 151.67%.
• Rockwell Medical's Non-Current Debt stood at $7.6 million in 2022, then rose by 9.77% to $8.3 million in 2023, then gained by 2.16% to $8.5 million in 2024, then grew by 4.18% to $8.8 million in 2025, then retreated by 7.01% to $8.2 million in 2026.
• The last three Non-Current Debt figures came in at $8.2 million (Q1 2026), $8.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.